Stockwinners Market Radar for August 01, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:42 EDT SPDR Gold Shares holdings rise to 827.82MT from 823.42MT - This is the highest level of holdings since June of 2018.

19:38 EDT Kayne Anderson MLP reports net assets $2.1B as of July 31 - Net asset value per share was $16.73.

18:47 EDT NetApp down 17% after Q1 guidance misses estimates, FY20 outlook lowered - In after-hours trade, shares are down approximately 17% to $47.95.

18:40 EDT Equitrans Midstream CEO acquires 100,000 common shares - In a regulatory filing, Equitrans Midstream chairman and CEO Thomas F. Karam disclosed the acquisition of 100,000 common shares of the company at a price of $16.11 per share.

18:27 EDT American Tower CEO: 5G is going to be a game-changer for society - In an interview on CNBC's Mad Money, American Tower CEO James Taiclet said: The Sprint/T-Mobile deal is good for the country as it will accelerate 5G development... The deal is also good for us... Our board continues to advocate a 20% annual increase in the dividend.

18:10 EDT Eldorado Gold CEO says 'on track' for 390,000-420,000 ounces of gold in 2019 - Eldorado's President and CEO, George Burns, stated: "It was a steady operational quarter with production and costs on plan. Two key milestones were achieved. We completed the debt refinancing, which de-risked our balance sheet, and we had a fantastic first quarter of commercial production at Lamaque. We are encouraged by our initial discussions with the Greek government. Realizing the potential of Eldorado's investments in Greece offers significant value for our investors, local communities and the Greek economy. We look forward to a strong second half of the year and are on track to meet our consolidated annual guidance of 390,000-420,000 ounces of gold at all-in sustaining costs of $900-1000 per ounce of gold sold."

17:58 EDT S&P announces changes to S&P 400, 500, 600 indices - S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Leidos Holdings (LDOS) and IDEX Corp. (IEX) will replace Anadarko Petroleum (APC) and Foot Locker (FL) respectively in the S&P 500, and Grubhub (GRUB) and Foot Locker will replace Leidos Holdings and IDEX in the S&P MidCap 400. These changes will be effective prior to the open of trading on Friday, August 9. Occidental Petroleum (OXY) is acquiring Anadarko Petroleum in a deal expected to be completed on or about that date pending final approvals. Foot Locker is more representative of the mid-cap market space, while IDEX and Leidos are more representative of the large-cap market space. National Beverage (FIZZ) will replace Barnes & Noble (BKS) in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, August 7. Elliott Management is acquiring Barnes & Noble in a deal expected to be completed on or about that date pending final conditions.

17:49 EDT Fluor provides 2H19 guidance on certain operational elements - In presentation slides, the company said, "Providing 2H 2019 guidance around certain operational elements: Corporate G&A of $100 million excluding restructuring charges and pension settlements, both of which are likely to be significant... No additional NuScale investments, which is based on 2H investment requirements being met by new investment from Doosan and Sargent & Lundy... Following CFIUS approval of these investments, we will no longer be incurring expenses for the remainder of this year."

17:46 EDT Fluor says 2H19 cash flow from operations 'likely to be negative' - In investor presentation slides, the company said, "Cash flow from operations for 2H 2019 likely to be negative as we fund troubled projects."

17:34 EDT BP awarded $157.5M Defense Logistics Agency contract for fuel - BP has been awarded a $157.5M fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for various types of fuel. This was a competitive acquisition with 21 offers received. The contract is a one-year contract with a 30-day carryover. Work has an October 30, 2020, performance completion date. Using customer is Defense Logistics Agency Energy. Type of appropriation is FY19 defense working capital funds. The contracting activity is the Defense Logistics Agency Energy.

17:31 EDT Royal Dutch Shell awarded $228.13M Defense Logistics Agency contract - Royal Dutch Shell has been awarded a $228.13M fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for various types of fuel. This was a competitive acquisition with 21 offers received. The contract is a one-year contract with a 30-day carryover. Work has an October 30, 2020, performance completion date. Using customer is Defense Logistics Agency Energy. Type of appropriation is FY19 defense working capital funds. The contracting activity is the Defense Logistics Agency Energy.

17:26 EDT BP awarded $315.6M Defense Logistics Agency contract - BP has been awarded a $315.6M fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for various types of fuel. This was a competitive acquisition with 21 offers received. The contract is a one-year contract with a 30-day carryover. Work has an October 30, 2020, performance completion date. Using customer is Defense Logistics Agency Energy. Type of appropriation is FY19 defense working capital funds. The contracting activity is the Defense Logistics Agency Energy.

17:22 EDT Foot Locker to replace IDEX Corp. in S&P 400 at open on 8/9

17:20 EDT IDEX Corp. to replace Foot Locker in S&P 500 at open on 8/9

17:17 EDT Leidos, IDEX Corp. set to join S&P 500

17:12 EDT Dolby increases stock repurchase program, declares dividend - Dolby announced that its board approved increasing the size of its stock repurchase program by $350M, bringing the amount available for future repurchases of the company's Class A common stock to approximately $415M. Additionally, Dolby announced a cash dividend of 19c per share of Class A and Class B common stock, payable on August 20 to stockholders of record as of the close of business on August 12.

17:10 EDT Phibro Animal Health acquires business, assets of Osprey Biotechnics - Phibro Animal Health Corporation announced it has acquired the business and assets of Osprey Biotechnics, Inc., a privately held developer and marketer of innovative microbial products. Acquiring the Osprey business strengthens Phibro's portfolio of nutritional specialty products and provides new opportunities in a fast-growing sector of the animal health industry. Osprey manufacturers and markets numerous products for a variety of applications and industries. Osprey also produces the key components for Phibro's recently launched Provia Prime direct fed microbial product for poultry. Phibro expects the transaction to be accretive to adjusted EBITDA and adjusted diluted EPS for the fiscal year ending June 30, 2020. Phibro funded the acquisition through its existing credit facilities.

17:08 EDT Orion Engineered reports Q2 adjusted EBITDA $71.5M vs. $81.1M last year - Reports Q2 volume 270.5KT vs.275.6KT.

17:07 EDT ICF International approves plan to name John Wasson as CEO - ICF announced that its Board of Directors has approved a succession plan that provides for the appointment of John Wasson, President, to the additional positions of CEO and member of the Board of Directors, effective October 1. John will succeed current CEO Sudhakar Kesavan, who will assume the position of Executive Chairman and remain closely involved in company strategy and operations. Wasson has held positions of increasing responsibility throughout his tenure at ICF. He has served as ICF's President since 2010 and its COO since 2003.

17:05 EDT We Energies, MGE announce plan for expanded solar partnership - We Energies and Madison Gas and Electric have announced a new partnership to acquire the remaining 150 megawatts of the Badger Hollow Solar Farm. We Energies and MGE filed a joint application with the Public Service Commission of Wisconsin. We Energies will own 100 MW, and MGE will own 50 MW

17:01 EDT Community Healthcare raises quarterly dividend to 41.25c per share - Payable on August 30 to shareholders of record on August 16.

16:55 EDT TimkenSteel provides Q3 outlook - The company said, "Shipments are expected to be 10 percent below the second quarter of 2019. Net loss is projected to be between $17 million and $27 million. EBITDA is projected to be between ($5M) and $5 million. Aligning production with demand will result in a decline in planned production levels in the third-quarter 2019 to 47 percent melt utilization from 57 percent utilization last quarter. This lower level of production, combined with the second half of planned annual maintenance of approximately $6 million dollars, will have a negative impact on fixed cost leverage and profitability during the third quarter. LIFO is projected to be a benefit of approximately $6 million. 2019 capital spending is projected to be approximately $50 million."

16:50 EDT Carl Icahn reports 12.62% stake in Cloudera, plans to seek talks - In a regulatory filing, Carl Icahn disclosed a 12.62% stake in Cloudera, saying he acquired the shares in the belief that the shares were undervalued. Icahn said he intends to seek to speak with representatives of the company's board of directors and management to discuss enhancing shareholder value and potentially seeking board representation. The Reporting Persons also intend to seek to have discussions with other stockholders to understand their perspectives and priorities. Icahn is considering all options and, while he has no present plan to do so, he reserves the right and is considering whether to propose other transactions. Shares of Cloudera rose 12.4% in after hours trading following the news.

16:49 EDT Ensign Group acquires Mainplace Senior Living - The Ensign Group announced that it acquired the operations of Mainplace Senior Living, a 91-unit assisted living community in Orange, California. The acquisition was effective August 1, and will be subject to a long-term, triple-net lease. Mainplace will become part of The Pennant Group on upon the completion of the previously-announced spin-off.

16:47 EDT Ensign Group acquires skilled nursing facility in Utah - The Ensign Group announced that it acquired the real estate and operations of The Terrace at Mt. Ogden, a skilled nursing facility with 114 skilled nursing beds located in Ogden, Utah. The acquisition was effective August 1.

16:45 EDT CRA International announces auction process for FirstEnergy Ohio utilities - CRA International (CRAI) announced that an auction process will be conducted for FirstEnergy Corp.'s (FE) Ohio utilities to procure full requirements service for their Standard Service Offer customers. The auction process will lead up to the auction scheduled for October 7, 2019. The bidding process will use a descending-price clock auction format. The auction will be managed by Auction Manager CRA International, Inc. The auction is being conducted pursuant to the FirstEnergy Ohio Utilities' Electric Security Plan as approved by the Public Utilities Commission of Ohio. This is the ninth auction in the series of ESP-IV auctions. The Information Session for prospective bidders for the October auction is scheduled for Wednesday, August 7, 2019. The products in the October 7 auction are a 12-month contract and a 24-month contract.

16:44 EDT Brixmor finalizes previously announced settlement with SEC - Brixmor Property Group announced that it has finalized its previously announced settlement with the SEC. As disclosed in February, the company reached an agreement with the SEC with respect to non-GAAP financial reporting matters that occurred prior to 2016 under Brixmor's former management team. The agreement includes a civil penalty of $7M, which was accrued by the company in the fourth quarter of 2018, and a commitment to engage an independent consultant to assess the company's current policies and procedures relating to certain non-GAAP performance measures. This regulatory settlement also follows the previously disclosed resolution of all related shareholder litigation. The company believes that no additional government proceedings relating to these matters will be brought against the company.

16:41 EDT Teradata increases repurchase authorization by $500M to $620M

16:39 EDT Everbridge acquires NC4 - Everbridge announced the acquisition of NC4, a global provider of threat intelligence solutions that empower businesses, government organizations, and communities to assess and disseminate risk data and information to manage and mitigate the impact of critical events. The aggregate consideration paid by Everbridge was approximately $83 million in cash and Everbridge stock. While the largest business component has been closed, additional components are not expected to be closed until the end of the third quarter. The acquisition, upon completion, is expected to be accretive to Everbridge's non-GAAP financial results within twelve months, and Everbridge will provide further financial details after completion of the entire transaction.

16:38 EDT Fulgent Genetics receives laboratory permit, genetic test approval from NYSDOH - Fulgent Genetics announced that the company has received approval from the New York State Department of Health, or NYSDOH, to offer next generating sequencing in the state of New York. The NYSDOH has issued to Fulgent Genetics a clinical laboratory permit in the category Genetic Testing - Molecular. Fulgent Genetics is now licensed to offer its tests to physicians and patients across New York State.

16:37 EDT LPL Financial completes acquisition of Allen & Company - LPL Financial Holdings announced the closing of its acquisition of Allen & Company of Florida, a broker-dealer and registered investment adviser based in Lakeland, Florida. As a result of the transaction, all 33 advisors joined LPL. Approximately $3B of client assets are expected to transfer onto LPL's platform by the end of 2019. The purchase agreement was signed on May 17, and the transaction closed on August 1, following receipt of regulatory approval. Under the transaction structure, Allen & Company advisors and staff joined LPL as employees, and Allen & Company will maintain its operations and brand. The company estimates a transaction multiple of approximately 7x post-synergy EBITDA.

16:34 EDT Glu Mobile reports Q2 bookings $101.9M vs. $99.4M last year

16:31 EDT Mammoth Energy suspends quarterly cash dividend

16:28 EDT Lippert Components acquires Lewmar Marine Limited - LCI Industries announced that its wholly-owned subsidiary Lippert Components, Inc., a supplier of a broad array of highly engineered components for the leading original equipment manufacturers of leisure vehicles and mobile transportation, and the related aftermarkets of those industries, has completed the acquisition of Lewmar Marine Limited, a supplier of leisure marine equipment, headquartered in Havant, United Kingdom. LCI had previously announced that it had submitted an offer to purchase Lewmar subject to approval by Lewmar's shareholders and the Scottish Court of Session. Lewmar's shareholders subsequently approved the transaction and the acquisition was completed by means of a court-sanctioned scheme of arrangement. Sales of the acquired business for the twelve months ending December 2018 were approximately GBP 55 million. LCI's accepted cash offer was approximately GBP 33.286 million, or approximately 143.65 pence per share, and allows for additional consideration up to GBP 2.5 million, or approximately 10.79 pence per share.

16:27 EDT Alexander & Baldwin raises quarterly dividend 15% to 19c per share - The dividend is payable on September 5 to shareholders of record as of the close of business on August 12.

16:24 EDT Lannett names John Kozlowski as CFO, succeeding Martin Galvan - Lannett announced the appointment of John Kozlowski as CFO, effective August 31. He succeeds Martin Galvan, who, as previously announced, will retire on August 30, following the planned submission of the company's Form 10-K for fiscal year 2019. Kozlowski presently serves as the company's chief of staff and strategy officer. Prior to joining Lannett, Kozlowski held senior finance positions with Finisar Australia and Optium Corporation.

16:20 EDT NetApp trading resumes

16:17 EDT Floor & Decor reports Q2 SSS up 3.0% - Q2 Adjusted EBITDA increased 31.4% to $66.6M from last year.

16:16 EDT BMC Stock Holdings acquires Kingston Lumber - BMC Stock Holdings announced that it has acquired Kingston Lumber, a supplier of building materials to custom builders and professional remodelers in Kingston, Washington. Sales for Kingston Lumber for the 12 months ended June 2019 were approximately $24M.

16:14 EDT First Solar down 8.9% after reporting Q2 earnings, reaffirming FY19 guidance

16:14 EDT GoDaddy reports CEO Scott Wagner stepped down for health reasons - GoDaddy reported the appointment of Aman Bhutani, previously President of Brand Expedia Group, as the company's new CEO, effective September 4, 2019. Scott Wagner, Chief Executive Officer, has stepped down for health reasons. Scott Wagner said, "The Board and I have worked to identify a tremendous successor and lay the groundwork for a smooth transition. Aman brings a wealth of experience to GoDaddy - an extraordinary track record in growing a scaled business, deep expertise in product and engineering, and strong delivery across go-to-market. Aman is an exceptional leader and has created strong followings in every organization he's led. He will fit in well with GoDaddy's culture, while drawing upon his comprehensive skills, mindset and experience to lead the company into the future."

16:09 EDT Etsy cuts FY19 adjusted EBITDA margin view to 22%-24% from 23%-25%

16:07 EDT DoorDash agrees to acquire Caviar, Square's food-ordering platform, for $410M - DoorDash announced that it has entered into a definitive agreement with Square to acquire Caviar for $410M in cash and DoorDash preferred stock. "DoorDash's acquisition of Caviar creates a highly differentiated company with a unique brand and wide-ranging selection," the company stated. Jack Dorsey, CEO of Square, said: "We are increasing our focus on and investment in our two large, growing ecosystems-one for businesses and one for individuals. This transaction furthers that effort, and we believe partnering with DoorDash provides valuable and strategic opportunities for Square." The transaction is subject to certain closing conditions, including regulatory approvals, and is expected to close in 2019.

16:06 EDT Continental Building lowers FY19 SG&A veiw to $38M-$40M from $39M-$41M - Total capital expenditures are expected to be in the range of $26 - $30 million, down from the previous range of $30 - $34 million.

16:05 EDT Hologic acquires 46% of shares in SuperSonic Imagine - Hologic and SuperSonic Imagine announced that Hologic Hub Ltd, a wholly-owned indirect subsidiary of Hologic, Inc., has acquired approximately 46% of SuperSonic Imagine shares, pursuant to a shares sale agreement entered into today. SuperSonic Imagine's main shareholders, namely Bpifrance, Andera Partners, Auriga Partners, Merieux Participations and CDC PME Croissance, holding together 10,841,409 shares, representing approximately 46% of the outstanding share capital of SuperSonic Imagine, sold all of their shares to Hologic at a price of EURO$1.50 per share. The settlement and delivery (reglement-livraison) of these shares to Hologic will effectively occur on August 2, 2019, it being specified that the acquisition is not subject to an earn-out mechanism. SuperSonic Imagine and Hologic also entered into a tender offer agreement setting forth the terms pursuant to which Hologic will proceed with the tender offer, the company's corporate governance commitments, commitments to conduct the company's business in the normal course of business, and certain representations and warranties. As previously announced by Hologic on June 20, 2019, Hologic has agreed to acquire SuperSonic Imagine's outstanding shares at a price of EURO$1.50 per share. This price corresponds to approximately $39 million for all outstanding shares, or approximately $42 million assuming all outstanding options with an exercise price lower than EURO$1.50 are exercised (based on the exchange rate of $1.13 for EURO$1). For information purposes, it is specified that Hologic will also make available funds to repay SuperSonic Imagine's net debt in an amount not to exceed $43 million, equating to a maximum enterprise value of $85 million (based on the exchange rate of $1.13 for EURO$1).

16:03 EDT Pinterest reports Q2 global ARPU 88c vs. 69c last year - Reports Q2 global MAUs up 30% at 300M

16:02 EDT Adverum Biotechnologies chief scientific officer Mehdi Gasmi to retire - Adverum Biotechnologies made several key personnel announcements. Board member and co-founder Mitchell Finer, Ph.D. is retiring from Adverum's Board of Directors to focus on his new industry role. In addition, Mehdi Gasmi, Ph.D. will retire from his position as president and chief scientific officer of Adverum, effective September 16, 2019, and will join Adverum's Board of Directors at that time.

15:59 EDT Eton reports FDA acceptance of New Drug Application for ET-105 - Eton Pharmaceuticals announced that Aucta Pharmaceuticals' New Drug Application for ET-105, an innovative formulation of lamotrigine which Eton acquired the U.S. marketing rights to in June 2019, has been accepted for review by the U.S. Food and Drug Administration. The FDA has assigned the application a Prescription Drug User Fee Act, or PDUFA, target action date of March 17, 2020. ET-105 is a patent-pending formulation of lamotrigine, for which Aucta is seeking approval as an adjunct therapy for partial seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome in patients two years of age and older.

15:50 EDT DOJ announces $3M settlement with Nissan Motor Acceptance Corporation - The Department of Justice announced that Nissan Motor Acceptance Corporation has agreed to pay $3M to resolve allegations that it violated the Servicemembers Civil Relief Act. The suit alleges that Nissan MAC repossessed 113 vehicles owned by SCRA-protected servicemembers without first obtaining the required court orders, and failed to refund up-front capitalized cost reduction amounts to servicemembers who lawfully terminated their motor vehicle leases early after receiving military orders.

13:47 EDT Canada Goose sinks 5% after NY Post report of scrubbed animal treatment claims - Shares of Canada Goose moved lower after Lisa Fickenscher of the New York Post reported that the company quietly scrubbed its website of guarantees about the "ethical" treatment of animals it uses for its outerwear. Canada Goose, which has faced a probe by the Federal Trade Commission over allegations of false advertising for over a year, has made "sweeping changes" to its website and other marketing materials, Fickenscher said. Following the report, shares of Canada Goose sunk 5%, or $2.25, to $44.56.

13:10 EDT Tyler 'Ninja' Blevins teams up with Microsoft's Mixer to stream games, video - Gaming superstar Tyler "Ninja" Blevins announced he is teaming up with Microsoft's interactive live streaming service, Mixer, to stream games and video exclusively on Mixer. Ninja will kick off his first Mixer stream during Lollapalooza 2019, from August 2 through August 4, at Ninja's Dojo inside the Red Bull Outpost. Ninja, who has more than 40M fans worldwide, commented, "Whether it's participating in events where I can connect with other people who love games or creating the best interactive streaming platform, Mixer inspires me to push the boundaries of gaming and opens up opportunities for me to interact with my community in more ways than ever before. I'm excited to continue doing what I've been doing - playing games and sharing my experiences with the world - and so much more."

13:04 EDT Entegra Financial shareholders approve merger with First Citizens - Entegra Financial Corp. (ENFC) and First-Citizens Bank & Trust Company (FCNCA) announced that Entegra's shareholders voted to approve First Citizens Bank's previously announced proposal to acquire Entegra and its wholly-owned subsidiary, Entegra Bank. Completion of the proposed acquisition is expected to occur during Q4. After the merger, Entegra Bank branch offices will initially operate as Entegra Bank, a division of First Citizens Bank. Entegra Bank's customer accounts will be converted to First Citizens Bank's systems and operations at a later date.

12:59 EDT Gamer Ninja says to stream exclusively on Microsoft's Mixer platform - Richard Tyler Blevins, more commonly known by his online alias Ninja, a professional gamer and streamer on Amazon's (AMZN) Twitch, announced that he will now stream exclusively on Microsoft's (MSFT) Mixer platform. Reference Link

12:45 EDT Zynga rises post-earnings as analysts back Buy-equivalent rating - Shares of Zynga (ZNGA) were trading higher after the mobile video game company reported quarterly results that beat expectations and provided upbeat guidance for the next quarter and fiscal year. Following the earnings release, no fewer than two analysts issued research notes maintaining Buy-equivalent ratings on the stock. EARNINGS: After the market close on Wednesday, Zynga reported second quarter earnings per share of (6c) on bookings of $376M, compared to analysts' estimates for 5c and $364.5M, respectively. The company noted that its live services continued to drive "great results," particularly with "Empires & Puzzles" and "Merge Dragons!" reaching "record" revenue and bookings in the quarter and "Words with Friends" achieving its best Q2 mobile revenue and bookings in franchise history. GUIDANCE: Looking ahead, the game maker said that, given "strong" momentum from live services, it opted to raise its fiscal 2019 revenue guidance to $1.24B and bookings guidance to $1.5B, up from its previous views of $1.2B and $1.45B, respectively. For the third quarter, Zynga said it expects bookings to be $380M on GAAP EPS of 26c. Analysts expect the company to report Q3 EPS of 5c on bookings of $366.96M. STEPHENS LIKES 2H SETUP: In a research note to investors, Stephens analyst Jeff Cohen maintained an Overweight rating on Zynga with a price target of $8.25, saying that investor expectations were high for this earnings report but the beat and raise "should be enough." Cohen said that Zynga showed "strong" sequential growth, especially from "Merge Dragons!," and was encouraged by the performance of the "Social Casino" portfolio. The analyst added that he "really" likes the setup for the second half of the year as numbers appear to be achievable based on existing games and new games should provide upside. He also said that he sees the potential for accretive M&A as the company as about $1.4B in cash and has signaled a willingness to use it for acquisitions. Cohen noted that a deal would be viewed positive by investors given Zynga's management team's track record of successful acquisitions. JEFFERIES SAYS RESULTS 'FAVORABLE: Meanwhile, Jefferies analyst Alex Giaimo backed a Buy rating on Zynga with a $7.50 price target, saying that the Q2 results reiterate his firm's view that Zynga is "uniquely positioned" to succeed within the fastest growing segment of gaming. Giaimo noted that bears will point to near-term margin compression, but he believes the company is taking a strategic approach to fuel multiple years of sustainable double digit growth. He also argued that, despite the 62% move higher year-to-date, the stock is still "cheap" at 17x estimated 2020 EBITDA. PRICE ACTION: In afternoon trading, Zynga is up 2.6% to $6.54.

12:42 EDT Occidental Petroleum sees FY19 total production 718-729 Mboed - Sees FY19 Permian Resources production of 283 - 287 Mboed. Sees FY19 international production of 278 - 283 Mboed.

12:35 EDT Occidental Petroleum sees Q3 total production 725-739 Mboed - Sees Q3 Permian resources production of 289 - 297 Mboed. Sees Q3 international production of 280 - 284 Mboed. Guidance provided in Q3 earnings presentation slides.

12:19 EDT Interactive Brokers reports July DARTs up 7% y/y - Interactive Brokers Group reported its Electronic Brokerage monthly performance metrics for July. Brokerage highlights for the month included: 800,000 Daily rage Revenue Trades, 7% higher than prior year and 1% lower than prior month. Ending client equity of $155.6B, 13% higher than prior year and 2% higher than prior month. Ending client margin loan balances of $26.5B, 6% lower than prior year and 3% higher than prior month. Ending client credit balances of $55.8B, including $2.1 billion in insured bank deposit sweeps1, 16% higher than prior year and 2% higher than prior month. 652,000 client accounts, 17% higher than prior year and 1% higher than prior month. 276 annualized rage cleared DARTs per client account. Average commission per cleared client order of $3.61 including exchange, clearing and regulatory fees.

12:11 EDT Stryker director Ronda Stryker sells over $19M in company shares - Stryker director Ronda Stryker disclosed in a filing that she had sold 90,182 shares of company stock at an average price of $214.06 per share on July 30. The total transaction value of the sale was $19,304,711.

12:00 EDT Boot Barn rises 17.1% - Boot Barn is up 17.1%, or $5.36 to $36.65.

11:58 EDT Hilton Grand Vacations says a buyer of stock 'at where we are today' - The company says it believes repurchases are the best use of its cash.

11:47 EDT Hilton Grand Vacations says 'actively revisiting' long-term targets - Says "actively revisiting" long-term targets based on the dynamics the company is seeing in the business. Comments taken from Q2 earnings conference call.

11:06 EDT Transact Technologies secures order for BOHA! solution deployments - TransAct Technologies Incorporated announced that it has secured a new agreement with a regional foodservice operator to deploy the BOHA! Terminal and one of the BOHA! SaaS-based apps. TransAct expects the customer's locations will go live with a total 128 BOHA! Terminals, the BOHA! Labeling SaaS-based app and TransAct Enterprise Management System by the end of 2019. The foodservice operator will also purchase TransAct Labels which are specifically designed to work with the thermal printers featured in the BOHA! Terminal and the Company's BOHA! Premier Express service offering. TransAct believes the annual recurring average revenue per unit for this agreement will be more than $1,100 a year. In addition, the foodservice operator is beginning an evaluation of three additional BOHA! SaaS-based apps for potential future deployments.

10:49 EDT Myriad jumps 37% to $40 after positive UnitedHealth coverage decision

10:39 EDT Myriad announces 'positive' coverage decision for GeneSight Psychotropic test - Myriad Genetics (MYGN) disclosed earlier today that UnitedHealthcare (UNH) has issued a "positive coverage decision" for pharmacogenetic testing for multi-gene panels including the company's GeneSight Psychotropic test. The coverage is for patients that have a diagnosis of major depressive disorder or anxiety and have failed at least one prior medication to treat their condition, Myriad said. The positive coverage decision is referenced in the UnitedHealthcare August 2019 Network Bulletin, it added.

10:31 EDT GM says looking to have 2,000 employees at Cruise unit by YE

10:13 EDT Mazda reports July U.S. sales down 3.5% to 23,292 vehicles - Mazda North American Operations reported total July sales of 23,292 vehicles, a decrease of 3.5% compared to July 2018. With 25 selling days in July, compared to 24 the year prior, the company posted a decrease of 7.3% on a Daily Selling Rate, or DSR, basis.

10:10 EDT Honda reports July U.S. sales up 1.9% to 141,296 units - American Honda reported July U.S. sales were up 1.9% from the same month of last year to 141,296 units. Honda division reported sales of 128,537, up 2.5%, and Acura reported sales of 12,759, down 3.7% year-over-year. "Despite industry headwinds, our strategic approach to the market continues to pay dividends for both the Honda and Acura brands. Honda strengthened its position as the #1 retail passenger car brand in America in July, even as we grow our SUV sales," said Henio Arcangeli, Jr., senior vice president of Automobile Sales at American Honda Motor.

10:08 EDT General Motors sees 2H China equity income generally in line with 1H

10:03 EDT Potbelly signs three new franchise agreements - Potbelly Corporation announced the signing of three new franchise agreements and the continued momentum in its franchising program. Over the last six months, Potbelly has signed franchise agreements that, when fully built out over the coming years, will nearly double its franchise footprint with multi-unit development deals for a total of 38 units spanning Las Vegas, Nevada; Tampa, Florida; and the Carolinas. In addition, Potbelly has opened a number of franchise stores this year that are driving brand penetration across several areas of the country, including recently opened shops in Irvine, California; Odessa, Texas; Richmond and Charlottesville, Virginia; Rochester, Minnesota; and Charlotte, North Carolina. Franchise agreements signed in the first and second quarters of 2019 are setting the course for Potbelly's accelerated franchise growth.

09:47 EDT Rayonier Advanced Materials rises 11.8% - Rayonier Advanced Materials is up 11.8%, or 55c to $5.20.

09:47 EDT Boot Barn rises 18.4% - Boot Barn is up 18.4%, or $5.77 to $37.06.

09:33 EDT Toyota reports July U.S. sales up 0.2% to 209,204 vehicles - Toyota Motor North America reported July sales of 209,204 vehicles, an increase of 0.2% on a volume basis and down 3.8% on daily selling rate, or DSR, basis versus July 2018. Toyota division posted July sales of 184,179 units, up 0.4% on a volume basis and down 3.6% on a DSR basis. Lexus division posted July sales of 25,025 vehicles, down 1.5% on a volume basis and down 5.4% on a DSR basis.

09:27 EDT Aleafia Health completes largest cannabis order to date - Aleafia Health is announcing that its wholly owned subsidiary, Emblem Cannabis Corporation, has completed the largest adult-use cannabis order in the Company's history. The value of the Order is expected to generate proceeds from the sale of cannabis exceeding $1M and has been shipped to a Canadian provincial government for distribution to online and retail consumers. The single Order features all of the Company's product formats and 17 individual product SKUs. Aleafia Health's average monthly gross revenue generated from the sale of cannabis now consistently and significantly exceeds equivalent revenues generated during Aleafia Health's entire 2018 annual reporting period. The Cultivation Licence application for the Company' modern, automated Niagara Greenhouse located in Grimsby, Ontario is now officially under review by Health Canada. In addition, 13,000 cannabis plants are now growing in the Company's Port Perry Outdoor Grow facility, including in the newly licensed Zone 2 area.

09:24 EDT Yum! Brands says feels it good about long-term outlook - Says pivoting from driving frequency to driving reach and frequency. Says pleased with progress in first half. Says need to restructure some Pizza Hut franchises with too much debt. Says tortilla supply issue impacted the company for nine days, Says tortilla impact was immaterial. Says unacceptable to run out of a core menu item. Says now has a total of 8,751 stores across more than 1,300 cities. Comments taken from Q2 earnings conference call.

09:21 EDT Elixinol Global, PharmaCare release hemp CBD capsules - Elixinol announced its latest product made in partnership with PharmaCare. Created in partnership with the prominent UK-based company, the Naturopathica CBD+ range encompasses six capsule-based SKUs that blend with Elixinol's high strength, full spectrum CBD products with specific vitamins and minerals to target different areas of wellbeing. The co-branded product brings high-quality hemp-derived CBD to consumers across the UK. With Naturopathica CBD+, the two companies will be creating a range of CBD-based products with additional supplements that help to support specific areas of health and wellbeing. Together, Elixinol and PharmaCare will maintain industry-leading certifications and provide seed-to-sale organic ingredient traceability.

09:20 EDT BioSig Technologies announces additional foundational patent for Pure EP system - BioSig Technologies announced that the US Patent Office has allowed another foundational patent including additional 29 patent claims covering its PURE EP System. The patent application number 16/271,466 entitled "Systems and Methods for Signal Acquisition and Visualization," was filed on May 9, 2018 and subject to an accelerated Track One patent application filed on February 8, 2019. The patent has not yet been published. The allowed claims provide even broader patent coverage for the company's PURE EP System and address the overall system architecture for filtering biomedical signals during a medical procedure such as an ablation procedure in frequency ranges of interest to the practitioner. The allowed claims address the novel system architecture related to a unique amplifier topology for conditioning cardiac and other physiologic signals, specifically to clearly define and record low-amplitude, frequency-specific information, which may be acquired during ablation and other large-signal perturbations, such as pacing. This ensures the acquisition of multiple low amplitude cardiac signals in the presence of numerous sources of electrical noise and environmental interference aside from the large signals injected during ablation and pacing.

09:17 EDT Del Frisco's adds plant-based steak offering to its menu - Del Frisco's Grille introduces four new and exciting dishes to its menu at all U.S. locations. With plant-based meats representing one of the hottest food trends among savvy consumers, Del Frisco's Grille is further satisfying needs for meat substitutes with its new Cauliflower Steak Frites - a great entree for anyone looking for an alternative to steak and seafood. Cauliflower no longer needs to be relegated to a side dish and rather can take center stage when dressed in the restaurant's unique golden raisin agrodolce, which elevates the dish's taste and presentation in a fresh way. The Grille also adds three new, healthful seafood interpretations to its ever-growing menu: a BBQ Shrimp Cobb Salad, Jumbo Shrimp Cocktail appetizer and a Mediterranean Shrimp Bowl featuring turmeric/

09:10 EDT Verizon says seeing continued strong trends in business wireless volumes - Says: Sees 2H19 wireless revenue growth in mid 2%-3% range...Seeing improving trends in Verizon Media Group... Continues to actively manage debt portfolio... Committed to strengthening the balance sheet... Will continue to be very disciplined with CapEx... First priority is to invest in the business...

09:07 EDT Black Knight and Docutech announce strategic alliance - Black Knight and Docutech have created a strategic alliance to bundle Docutech's advanced ConformX document generation engine as part of Black Knight's comprehensive Origination Suite of solutions. Using rules-based intelligence and pre-configured automation capabilities, data is imported and systematically populated on the required documents generated by the lender to streamline onboarding.

09:06 EDT OHA Investment to merge with Portman Ridge Finance Corporation - OHA Investment Corporation and Portman Ridge Finance Corporation announced that they have entered into a definitive agreement under which OHAI will merge with and into PTMN, a business development company managed by Sierra Crest Investment Management LLC, an affiliate of BC Partners Advisors L.P. and LibreMax Capital LLC. The transaction is the result of OHAI's previously announced review of strategic alternatives and has been approved by a unanimous vote of the Special Committee of the Board of Directors of OHAI, the Board of Directors of OHAI and the Board of Directors of PTMN. Transaction Highlights: The combined company will be externally managed by Sierra Crest and is expected to have total assets of approximately $372 million, and net asset value of approximately $181 million; OHAI stockholders will benefit from PTMN's lower fee structure and should expect to realize net investment income, net asset value and distribution accretion within the first year following closing of the transaction; Following the transaction, current OHAI stockholders are expected to own approximately 16% of the combined company; OHAI's credit facility will be paid off in full at the closing of the transaction. Based on PTMN's lower borrowing cost, the combined company can expect to realize interest savings of approximately $0.5 million per annum; The transaction is expected to deliver operational synergies for the combined company as a result of the pro forma larger scale and elimination of redundant OHAI expenses; Pursuant to the merger agreement, if at any time within one year after the closing date of the transaction shares of PTMN are trading at a price below 75% of its net asset value, PTMN will initiate a share buyback program of up to $10 million to support the trading price of the combined entity for up to one year from the date such program is announced; PTMN stockholder approval is not required for the merger transaction, contributing to additional certainty of closing. Under the terms of the proposed transaction, OHAI's stockholders will receive value per share of approximately 108% of OHAI's net asset value per share at the time of the closing of the transaction from PTMN and Sierra Crest. As of March 31, 2019, OHAI's net asset value was $37.1 million, or $1.84 per share. In connection with the transaction, OHAI stockholders will receive a combination of a minimum of $8 million in cash from PTMN; PTMN shares valued at 100% of PTMN's net asset value per share at the time of closing of the transaction in an aggregate number equal to OHAI's net asset value at closing minus the $8 million PTMN cash merger consideration; and an additional cash payment from Sierra Crest, the external adviser to PTMN, of $3 million in the aggregate, or approximately $0.15 per share. Assuming a transaction based on respective March 31, 2019 net asset values for OHAI and PTMN, adjusted for expected transaction expenses, and PTMN's 60-day volume weighted average price through July 30, 2019 of $2.57, the merger transaction currently values OHAI shares at approximately $1.46 per share which represents 83% of OHAI's March 31, 2019 net asset value and a 35% premium to OHAI's closing price on July 30, 2019. The parties currently expect the transaction to be completed in the fourth calendar quarter of 2019.

09:04 EDT Fly Intel: Pre-market Movers - UP AFTER EARNINGS: Verizon (VZ), up 1.5%... General Motors (GM), up 3%... Cigna (CI), up 1%... DuPont (DD), up 2%... Yum! Brands (YUM), up 3%... Shopify (SHOP), up 5%... AmerisourceBergen (ABC), up 2%... Crocs (CROX), up 13%. ALSO HIGHER: Aveo Pharmaceuticals (AVEO), up 18% after announcing that the company has amended their license agreement to allow Kyowa Kirin to buy back the non-oncology rights of tivozanib in Aveo territories, which includes the U.S. and EU. DOWN AFTER EARNINGS: Qualcomm (QCOM), down 5%... Clorox (CLX), down 4%... Wayfair (W), down 1.5%... Yeti (YETI), down 2%... Abiomed (ABMD), down 19%. ALSO LOWER: TCF Financial (TCF), down 3% after leaving the S&P 400.

09:03 EDT Raytheon awarded $108M Navy contract in Afghanistan - Raytheon has been selected by the U.S. Army Contracting Command to train the Afghanistan Air Force in aircraft maintenance. Raytheon will develop a new training program for the U.S. Army's Program Executive Office for Simulation, Training and Instrumentation under the $108M contract, called Afghanistan Air Force Aircraft Maintenance Training, or AMT.

09:01 EDT II-VI says SAMR has not requested refiling of application for Finisar deal - The company said, "Correcting inaccurate media reporting, II-VI Incorporated (IIVI) announced that it has not been requested by the State Administration for Market Regulation of the People's Republic of China to re-file the application for clearance that II-VI previously filed with SAMR with respect to II-VI's pending acquisition of Finisar Corporation (FNSR) SAMR's review of the Merger is currently in Phase III, which ends on August 17, 2019. II-VI will make a subsequent announcement either when SAMR approves the Merger, or if Phase III expires and II-VI re-files in order to provide additional time for SAMR to review the transaction."

08:56 EDT Cadiz enters SoCal Hemp joint venture with Glass House Farms - Cadiz announced it has entered into a joint venture partnership with Glass House Farms, a division of California Cannabis Enterprises. The JV is a 50-50 shared venture of Cadiz and Glass House Farms, which will operate under the name SoCal Hemp Co. The JV will work to sustainably cultivate organic, sun-grown, industrial hemp on up to 9,600 acres at the Cadiz Ranch in San Bernardino County, California. Hemp is now legal to grow and market in all 50 States, following the passage of the 2018 U.S. Farm Bill. The JV intends to bring to market hemp and hemp-derived products and solutions at a commercial scale to meet growing business and consumer market demands. The formation of SoCal Hemp Co. has the potential to create the largest, vertically integrated, commercial hemp operation based in the world's fastest-growing hemp market - California. In June, Cadiz and Glass House Farms led an experimental commercial hemp program to research the potential for large-scale commercial production of hemp on five acres at the Cadiz Ranch, which has already buoyed confidence in the viability of growing hemp on site. In compliance with all state, federal and local regulatory requirements, the JV will now work to expand its operation to 60 acres next month, 1,280 acres in 2020 and approximately 9,600 acres over the next three years. The joint venture will work openly and transparently with the County of San Bernardino and law enforcement in ensuring that it maintains a first class, safe and secure farming operation. Cadiz intends for revenues derived from hemp-based cultivation and processing to meet our objective of cash-flow positive business operations inclusive of water project objectives. Cadiz expects the production of hemp to be fully compatible with the Cadiz Water Project. Overlying farming demands will be coordinated with project operations and existing Court-validated permits. Cadiz will also continue to support the further scientific review of area mountain springs and water dependent ecosystems as called for in recently adopted legislation, and nothing in this venture diminishes that commitment.

08:53 EDT Synchronoss parnters with Arrow Electronics for smart building solutions - Synchronoss Technologies (SNCR) announced an agreement with Arrow Electronics (ARW) to develop and bring to market a new end-to-end IoT smart building solution. Intended for use by telecom operators, service providers and system integrators, the solution will allow users to remotely monitor and manage key automated on-premise features and systems, including heating, ventilation and air conditioning; lighting; security; maintenance; and energy consumption. The joint solution will incorporate the Synchronoss Smart Buildings Platform, which brings together data from disparate in-building systems and sensors into a single, unified dashboard. The Synchronoss platform aggregates and analyses the data in real-time to uncover new insights and provide recommendations to solve problems, improve operational performance and reduce running costs for buildings. This will combine with Arrow's own expertise in creating and configuring hardware-based in-building management systems to provide a single, integrated package which telecom operators, system integrators and other service providers can offer to large multi-national companies and organizations to remotely manage their premises' on-site automated features.

08:50 EDT Habit Restaurants to expand in New England with 7-store franchise deal - The Habit Restaurants announces plans to expand to Massachusetts and New Hampshire in a 7-store development agreement with Adam Quinn of Heidi Burgers, LLC. The first Habit Burger Grill restaurant is expected to open in the spring of 2020. Heidi Burgers will open Habit locations in the Middlesex and Essex Counties in Massachusetts with the first location planned for the company's backyard of Wilmington.

08:47 EDT Neogen's Reveal Q+ for DON test approved by AOAC Research Institute - Neogen has received Performance TestedSM Method Certification from the AOAC Research Institute for its Reveal Q+ for Deoxynivalenol - DON - test, which is designed for the rapid quantification of the mold toxin in grains. The AOAC approval follows the earlier verification of the test's performance by the USDA's Federal Grain Inspection Service. FGIS's approval of Reveal Q+ for DON enabled the simple, fully quantitative lateral flow strip test to be used for testing in the national grain inspection system. Reveal Q+ for DON delivers results ranging from 0.3 to 6 parts per million (of DON after 3 minutes. DON is produced by the fungi living on cereal commodities such as wheat, corn and barley.

08:46 EDT Bellerophon completes enrollment in cohort 2 of Phase 2/3 study of INOpulse - Bellerophon Therapeutics announced that it has completed enrollment for Cohort 2 of its ongoing Phase 2/3 randomized, double-blind, placebo-controlled clinical study of INOpulse for the treatment of Pulmonary Hypertension associated with Interstitial Lung Disease. Cohort 2 of iNO-PF includes 44 subjects randomized 2:1 to either iNO45 or placebo. Subjects will complete 16 weeks of blinded treatment on iNO45 vs placebo, and then continue onto open-label treatment.In January 2019, Bellerophon reported top-line data from Cohort 1 of iNO-PF, which included 41 subjects randomized 1:1 to either iNO30 or placebo for 8 weeks of blinded treatment. Cohort 1 showed clinically meaningful improvements in multiple activity parameters, as well as oxygen saturation: MVPA improved by 34%; 23% of subjects on iNO had a clinically significant improvement in MVPA, compared to 0% of subjects on placebo; 39% of subjects on iNO had a clinically significant decline in MVPA, compared to 71% of subjects on placebo; Overall activity improved by 12%; Calorie expenditure improved by 12%; Oxygen saturation improved by 20%; Cohort 3 of iNO-PF is the pivotal Phase 3 study for approval, with MVPA as the primary endpoint. The study is expected to include approximately 300 subjects randomized 1:1 to active or placebo for 16 weeks of blinded treatment.

08:41 EDT Verizon says had a 'strong second quarter' - Says: Focusing on fiber and 5G deployment... Seeing a lot of traction from enterprise customers... Transforming to Verizon 2.0 from a position of strength... On track for $10B in cost savings by 2021. Comments taken from Q2 earnings conference call.

08:37 EDT TransUnion appoints Eli Peterson as Deputy General Counsel - TransUnion announced that Eli Peterson will join the company as Deputy General Counsel for Public Policy and Privacy effective August 5. In this new position, Peterson will lead the global groups responsible for public policy, government relations, regulatory advocacy, and privacy. With senior management, Eli will drive enterprise strategy pertaining to the intersection of TransUnion's major businesses with governmental bodies globally and lead the firm's cross-business legal support on all privacy matters. Based in Washington, D.C., Peterson will report directly to Heather Russell, TransUnion's Executive Vice President and Chief Legal Officer. Peterson joins TransUnion from BNY Mellon where he was a Managing Director.

08:34 EDT IBM transforms software to run on any Cloud with Red Hat - IBM (IBM) announced that it has transformed its software portfolio to be cloud-native and optimized it to run on Red Hat (RHT) OpenShift. Enterprises can now build mission-critical applications once and run them on all leading public clouds, including AWS, Microsoft Azure, Google Cloud Platform, Alibaba and IBM Cloud and on private clouds. The new cloud-native capabilities will be delivered as pre-integrated solutions called IBM Cloud Paks. The IBM-certified and containerized software will provide a common operating model and common set of services - including identity management, security, monitoring and logging - and are designed to improve visibility and control across clouds together with a unified and intuitive dashboard.

08:32 EDT Wayfair sees Q3 revenue 'just below current QTD forecast,' consensus $2.31B - Sees Q3 revenue just below current QTD forecast. Sees Q3 direct retail net revenue $2.22B-$2.27B. Sees Q3 CapEx about 4%-5% of net revenue. Expects U.S. business to swing to a loss this coming quarter. Says y/y direct retail gross revenue growth is running in the mid-30s so far in Q3, somewhat lower than the end of Q2.

08:26 EDT Eton Pharmaceuticals announces FDA acceptance of NDA for ET-105 - Eton Pharmaceuticals announced that Aucta Pharmaceuticals' New Drug Application for ET-105, an innovative formulation of lamotrigine which Eton acquired the U.S. marketing rights to in June 2019, has been accepted for review by the U.S. Food and Drug Administration. The FDA has assigned the application a Prescription Drug User Fee Act target action date of March 17, 2020. ET-105 is a patent-pending formulation of lamotrigine, for which Aucta is seeking approval as an adjunct therapy for partial seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome in patients two years of age and older. Lamotrigine is one of the most widely used anti-epilepsy medications in the U.S. with sales exceeding $700 million and 1 billion tablets annually but is only FDA-approved in tablet formulations. ET-105's innovative formula will be delivered to patients as an oral liquid and has been developed specifically to address the significant unmet need in patients with dysphagia and pediatric patients requiring precision dosing at levels below the currently available tablet strengths.

08:25 EDT TRACON, I-Mab Biopharma dose first patient in Phase 1 trial of TJD5 - I-Mab Biopharma and TRACON Pharmaceuticals jointly announced that TRACON has dosed the first patient in a U.S. Phase 1 first-in-human clinical trial of I-Mab's proprietary CD73 antibody TJD5, also known as TJ004309, in patients with advanced solid tumors. TJD5 will be dosed in the Phase 1 trial both as a single agent and in combination with TECENTRIQ, a PD-L1 antibody marketed by Roche. I-Mab entered into a research collaboration with Roche in April 2019 where Roche agreed to supply TECENTRIQ to I-Mab for use in clinical study in combination with TJD5. The multicenter, open-label, dose escalation Phase 1 study will evaluate safety and tolerability of TJD5, and determine a recommended dose for further clinical studies of its efficacy and safety as a single agent and in combination with standard dose TECENTRIQ in patients with advanced or metastatic cancer who are refractory to or intolerant of all available therapy. TJD5, a novel, differentiated humanized antibody against CD73, is from I-Mab's proprietary discovery pipeline being co-developed through a corporate collaboration between TRACON and I-Mab signed in November 2018. The two companies have a second broader strategic partnership to develop up to five bispecific antibodies from I-Mab's immuno-oncology portfolio.

08:22 EDT Pfenex, Arcellx announce development, evaluation and license agreement - Pfenex and Arcellx announced a Development, Evaluation and License agreement under which Arcellx gains access to the proprietary Pfenex Expression Technology platform to advance multiple proprietary sparX proteins that activate, silence and reprogram Antigen- Receptor Complex T cell based therapies. Pfenex has successfully completed expression screening and process development activities for the first sparX program. Technology transfer of the program to a cGMP manufacturing facility is underway. The success of the first program has encouraged both parties to initiate a second sparX program, both programs are focused on the treatment of hematologic malignancies. Under the terms of the agreement, Pfenex is eligible to receive development funding in addition to development, regulatory and commercial milestones ranging from $2.6M up to $18M for each product incorporating a SparX protein expressed using the Pfenex Expression Technology as well as royalties on worldwide sales of any such products.

08:20 EDT Aveo Oncology to sell non-oncology rights of tivozanib back to Kyowa Kirin - Kyowa Kirin and Aveo Oncology announced that they have amended their license agreement to allow Kyowa Kirin to buy back the non-oncology rights of tivozanib in Aveo territories, which includes the U.S. and EU. The agreement is an amendment to the terms of the 2006 tivozanib license agreement between Kyowa Kirin and AVEO which granted AVEO exclusive rights of tivozanib in all indications. Under the terms of the amended license agreement, Kyowa Kirin will reobtain the non-oncology rights of tivozanib in Aveo territories excluding the rights which are currently sublicensed to EUSA Pharma. Kyowa Kirin will be obligated to a $25M upfront payment to Aveo, waive Aveo's obligation to make an $18M milestone payment upon Aveo gaining U.S. marketing approval, and up to $391M in potential milestone payments upon the successful achievement of certain development and commercial objectives in non-oncology indications of tivozanib. Kyowa Kirin will also be obligated to make tiered royalty payments on the net sales of these indications, which range from a high single-digit to low double-digit percent.

08:20 EDT Restaurant Brands' Burger King announces nationwide launch of Impossible Whopper - Burger King announced earlier that it is bringing the plant-based Impossible Whopper sandwich nationwide this month. Starting on August 8, guests across the nation will be able to try the Impossible Whopper for a limited time only, the company stated. Impossible Foods is a privately-held rival of Beyond Meat (BYND). Burger King is a unit of Restaurant Brands (QSR).

08:16 EDT Bausch Health resolved Apriso intellectual property litigation with Teva - Bausch Health Companies (BHC), along with its wholly owned subsidiary, Salix Pharmaceuticals, last night announced that it has agreed to resolve the outstanding intellectual property litigation with Teva Pharmaceuticals (TEVA) regarding Apriso extended-release capsules 0.375g. Under the terms of the agreement, Salix will grant Teva a non-exclusive license effective Oct. 1, 20211 to the Salix intellectual property relating to Apriso in the United States. Bausch Health will not make any financial payments or other transfers of value as part of the agreement. The parties have agreed to dismiss all litigation related to Apriso, and intellectual property protecting Apriso will remain intact and enforceable, Bausch added. The company said it will "continue to vigorously defend its intellectual property." The final patent expiry on Apriso is 2030. Bausch Health has also amended its prior sub-license agreement with Lupin Pharmaceuticals and two other paragraph IV filings remain, it noted.

08:12 EDT General Motors up 3% to $41.58 after Q2 results beat estimates

08:10 EDT Agile Therapeutics sees cash, cash equivalents sufficient through end of 2019 - As of June 30, 2019, Agile had $10.6 million of cash and cash equivalents compared to $7.8 million of cash and cash equivalents as of December 31, 2018. During the quarter ended June 30, 2019, the Company raised net proceeds of approximately $1.4 million from the sale of 992,072 shares of common stock from its "at-the-market" equity offerings. The Company believes its cash and cash equivalents as of June 30, 2019 will be sufficient to meet its projected operating requirements through the end of 2019. The Company will require additional capital to fund operating needs for 2020 and beyond, which will include, among other items, the completion of its commercial plan for Twirla, if approved, which primarily includes validation of the commercial manufacturing process and the commercial launch, and advancing the development of its other potential product candidates.

08:08 EDT General Motors says $1.1B in cost savings achieved year-to-date - Significant progress on transformational cost initiatives with $1.1B in savings achieved year-to-date.

08:06 EDT General Motors: China industry unit sales are expected to remain weak in 2H19 - The company said, "Due to China's economic slowdown, China industry unit sales are expected to remain weak through the second half of the year, with industry deliveries projected to be down for the full year. GM China expects to benefit from about 20 new vehicle launches, the majority of which will go on sale later in the year. Nearly two thirds of the launches in the second half are SUVs. However, GM expects equity income in the second half of the year to be generally in line with the first half, due to ongoing headwinds."

08:05 EDT Camber Energy says agrees to support 'active' acquisition program - Camber Energy provided an update based on multiple requests from its shareholders. As disclosed previously, following the company's acquisition of Lineal Star Holdings, the company changed its business focus to growing its midstream and downstream pipeline integrity services, specialty construction and field services. Lineal's historical and existing business relationships include 43 Master Service Agreements with top tier pipeline and utility companies and a large portfolio of current bidding opportunities. Lineal's subsidiary in Pittsburgh is continuing its existing contract work as well as bidding on new work on a weekly basis. As a major part of the post-transaction business plan with Lineal, Camber has agreed to support an active acquisition program. "To demonstrate our commitment as part of the closing of the transaction, the Company has previously transferred $4 million to a dedicated bank account to be used, along with planned future debt funding, to close acquisitions that meet the Company's criteria. The Company is continuing to review possible acquisitions on an ongoing basis." The company would also like to confirm to shareholders that one requirement of the closing with Lineal was that Lineal have a negotiated enterprise value of at least $20M, which value was deemed fair by an independent third-party.

08:02 EDT Cimpress sees Vistaprint's revenue growth for FY20 'flat to negative' - The company said: "We are hopeful that there is opportunity for Vistaprint to grow again beyond fiscal year 2020 but we will not comment further on this because we do not yet have enough history following our advertising reductions." Cimpress sees National Pen's constant-currency organic revenue growth to fall between zero and thelow single-digits in fiscal year 2020. It added: "On an unlevered free cash flow (albeit pre-tax, pre-working capital) basis, we expect the midpoint of our estimated range of organic investment not required to maintain a steady state will decrease by $23 million from fiscal year2019 to fiscal year 2020, and we expect the midpoint of the estimated range of operating income and adjusted NOPimpact of these investments to decrease by $37 million." Comments taken from the company's annual letter to shareholders.

08:00 EDT Hudbay Minerals to appeal Rosemont court decision - Hudbay Minerals announced that late yesterday the U.S. District Court for the District of Arizona issued a ruling in the lawsuits challenging the U.S. Forest Service's issuance of the Final Record of Decision for the Rosemont project in Arizona. The Court ruled to vacate and remand the FROD such that Rosemont cannot proceed with construction at this time. Hudbay believes that the Court has misinterpreted federal mining laws and Forest Service regulations as they apply to Rosemont. As such the company will be appealing the Court's decision to the U.S. Ninth Circuit Court of Appeals. The FROD was issued in June 2017 after a thorough process of ten years involving 17 co-operating agencies at various levels of government, 16 hearings, over 1,000 studies, and 245 days of public comment resulting in more than 36,000 comments. "We are extremely disappointed with the Court's decision. We strongly believe that the project conforms to federal laws and regulations that have been in place for decades," said Peter Kukielski, Interim President and Chief Executive Officer. "We will be appealing the decision as we evaluate next steps for the Rosemont Project."

07:57 EDT Adaptimmune promotes John Lunger to chief patient supply officer - Adaptimmune Therapeutics announced changes to its Executive Team. "In the last two weeks, we have announced the start of three new clinical trials, illustrating our increased focus on rapid execution," said Adrian Rawcliffe, incoming Adaptimmune CEO. "We are also announcing changes to our Executive Team. The role of manufacturing and supply chain in meeting our obligations to patients is critical as we prepare to launch a SPEAR T-cell therapy in 2022. So, I am delighted that John Lunger is being promoted to the Executive Team as Chief Patient Supply Officer to further build our state-of-the-art manufacturing and supply chain organization. We are also announcing that Rafael Amado has decided to leave Adaptimmune to pursue other opportunities. I wish him success in this next phase of his career and thank him for the role he has played in building our R&D capabilities. We are fortunate to have a talented team of R&D leaders in place to continue the work we do for patients." John Lunger, Adaptimmune's new Chief Patient Supply Officer, who was previously SVP Manufacturing and Supply Chain, has played a leadership role in establishing Adaptimmune's fully integrated supply capabilities. John will continue to strengthen the Company's ability to deliver products to patients, accelerate execution, and optimize the supply chain to be ready for commercialization. Prior to joining Adaptimmune in 2017, John was Head of Supply Chain and Commercial Product Supply at Merrimack Pharmaceutical.

07:52 EDT Xynomic Pharmaceuticals files Fast Track Designation application for abexinostat - ynomic Pharmaceuticals Holdings announced that it has filed an application with the U.S. Food and Drug Administration seeking Fast-Track designation for its drug candidate abexinostat as a monotherapy for the treatment of relapsed or refractory follicular lymphoma. The U.S. FDA has already granted Fast-Track designation to abexinostat, in combination with pazopanib, as a first- or second-line treatment of renal cell carcinoma A global, randomized pivotal Phase 3 trial is underway to test abexinostat combined with pazopanib as a first- or second-line therapy in patients with locally advanced or metastatic RCC.

07:51 EDT Terex completes sale of Demag Mobile Cranes business for $215M - Terex Corporation announced that it has completed the sale of its Demag Mobile Cranes business to Tadano for an enterprise value of approximately $215M. The final transaction consideration is subject to post-closing adjustments for cash, debt and net working capital. Moelis & Company LLC acted as financial advisor to Terex on this transaction. Bryan Cave Leighton Paisner LLP acted as legal counsel to Terex on this transaction.

07:46 EDT Izea announces seven-figure contract win - IZEAWorldwide announced that is has secured a seven-figure contract with a new customer, a manufacturer who ranks among the top 500 public companies globally. In addition, the company has signed a new Fortune 1000 beauty brand, and expanded its relationship with a major movie studio as well as an existing Fortune 10 customer.

07:42 EDT TransEnterix announces broad reimbursement approval in Japan - TransEnterix announced that Japan's Ministry of Health, Labour and Welfare, or MHLW, expert review panel provided reimbursement for procedures performed with the Senhance Surgical System. The reimbursement, which became effective on July 31, applies to 98 benign and malignant laparoscopic procedures across general, colorectal, gynecologic, bariatric and urologic surgeries at reimbursement rates equivalent to traditional laparoscopy in Category A1. The Senhance received regulatory approval from the Japanese MHLW on May 22.

07:38 EDT Intellia expects cash, cash equivalents to fund requirements into 2H21 - Intellia expects that its cash, cash equivalents, marketable securities and proceeds due from the ATM offerings as of June 30, 2019, as well as technology access and funding from Novartis and Regeneron, will enable Intellia to fund its anticipated operating expenses and capital expenditure requirements into the second half of 2021. This expectation excludes any potential milestone payments or extension fees that could be earned and distributed under the collaboration agreements with Novartis and Regeneron or any strategic use of capital not currently in the Company's base-case planning assumptions.

07:36 EDT Linde plc starts up new plant to supply Evonik complex in Singapore - Linde announced that it has started up a new gas production facility supplying methane, hydrogen and carbon dioxide to Evonik Industries' second world-scale methionine complex on Jurong Island in Singapore. The new plant complements an existing facility which has been supplying these gases to Evonik's first methionine complex in Singapore since 2014.

07:33 EDT Teleflex reports publication of study on MANTA percutaneous closure device - Teleflex announced the publication of the "Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device." The SAFE MANTA IDE Clinical Trial evaluated the safety and effectiveness of the MANTA Device. The study demonstrated that, in a selected population, the MANTA Device can close large bore arteriotomies created by current generation transcatheter aortic valve replacement, percutaneous endovascular abdominal aortic aneurysm repair, and thoracic endovascular aortic aneurysm repair devices. The study demonstrated that the median time from deployment to hemostasis was 24 seconds. Technical success was achieved in 97.7% of patients, and a single device was deployed in 99.6% of cases. The IDE-defined major complications, the primary safety end point for the study, occurred in 5.3% of patients and Valve Academic Research Consortium-2 major vascular complications occurred in 4.2% of cases.This VARC-2 rate is lower than published rates for suture-mediated closure.

07:32 EDT IntercontinentalExchange sees Q3 data revenues $550M-$555M - ICE's third quarter 2019 GAAP operating expenses are expected to be in a range of $632 million to $642 million and adjusted operating expenses are expected to be in a range of $552 million to $562 million. ICE's interest expense is expected to be $73 million in the third quarter.

07:31 EDT Adaptimmune sees cash, cash equivalents funding operations through 3Q20 - The Company believes that its existing cash, cash equivalents and marketable securities will fund the Company's current operations through the third quarter of 2020.

07:29 EDT Axonics reports 1-year results from study of r-SNM System for incontinence - Axonics completed 1-year follow-ups and top-line clinical results from its ARTISAN-SNM pivotal clinical study conducted under an FDA Investigational Device Exemption designed to evaluate the safety and efficacy of the Axonics r-SNM System. The study results at 1-year demonstrate that patients implanted with the Axonics r-SNM System continue to receive "clinically meaningful and statistically significant improvements in urinary urgency incontinence symptoms and quality of life". At 1-year, 89% of all implanted subjects were therapy responders, consistent with the 90% therapy responder rate reported at 6-months. Therapy responders at follow-up were identified as patients with at least a 50% reduction in urinary urgency incontinence episodes compared to baseline. There were no serious adverse device related events or unanticipated device related events. The results at 1-year show consistent symptom decrease, quality of life improvement, and patient satisfaction as the previously reported 6-month study results.

07:27 EDT McDermott awarded EPCI contract by Saudi Aramco - McDermott announced it has been awarded a contract by Saudi Aramco to provide engineering, procurement, construction and installation, or EPCI, of a production deck module, or PDM, in the Hasbah gas field with hook-up and modification works in Saudi Arabia's Karan fields located offshore in the Arabian Gulf. The scope of work includes EPCI of Wellhead PDM for four wells, 3.75 miles of 16-inch corrosion resistant alloy cladded flowline, 4 miles of subsea umbilical cable, offshore tie-ins to existing facilities and electrical modifications to existing PDMs. Engineering of the project will be performed in Saudi Arabia and fabrication will take place at McDermott's Jebel Ali yard in the United Arab Emirates. Fabrication is expected to begin in Q2of 2020 and the contract award will be reflected in McDermott's Q3 backlog.

07:24 EDT Penn National CEO Timothy Wilmott to retire, Jay Snowden to succeed - Penn National announced that in connection with its ongoing succession process, Timothy Wilmott informed the company's board of his decision to retire as CEO of the company and as a member of the board at the end of 2019. Effective January 1, 2020, the board has appointed Jay Snowden, who since 2014 has served as COO and since 2017 as president, to succeed Wilmott. Snowden was also appointed to Penn National's board effective immediately. Wilmott joined Penn National in February 2008 as president and COO, was named CEO in November 2013 and has served as a member of the board of directors since 2014. Snowden joined the company in October 2011 as senior VP-regional operations. In January 2014, Snowden was appointed COO and in March 2017, Snowden became president and COO. Along with his responsibility for operations, marketing, interactive, IT and human resources, Snowden has led the company's integration with Pinnacle Entertainment and its margin initiatives.

07:17 EDT Ingredion to expand portfolio of plant-based proteins - Ingredion announced it will further expand its manufacturing and production capabilities in Vanscoy, Saskatchewan with Verdient Foods. As part of this investment, the company has begun construction on a new manufacturing facility to produce specialty pulse-based protein ingredients. The new facility, which is expected to be operational in the second half of 2020, significantly increases the company's food processing capabilities to meet the growing consumer demand for plant-based proteins. The company announced an increased investment in plant-based proteins to $185M from $140M, by fourth quarter 2020.

07:15 EDT Elanco acquires Prevtec Microbia for approximately $59.9M - Elanco Animal Health announced the acquisition of Montreal-based Prevtec Microbia, a biotechnology startup specializing in the development of vaccines that help prevent bacterial diseases in food animals. Under the terms of the agreement, Elanco acquired the company, including inventory and pipeline assets in an all-cash deal for approx. $59.9M. The agreement also includes a contingent payment of up to approx. $16.4M to the former Prevtec shareholders in Q1 2022, if certain sales milestones are achieved in 2021.

07:08 EDT Pieris: Cash, cash equivalents totaled $99.7M as of June 30

07:06 EDT Agios Pharmaceuticals sees cash, cash equivalents sufficient through end of 2020 - Cash, cash equivalents and marketable securities as of June 30, 2019 were $624.0 million compared to $805.4 million as of December 31, 2018. The net decrease of $181.4 million in cash position was primarily driven by net expenditures to fund operations, including a onetime cash expense of $19.2 million for bonus payouts during the first quarter. The company expects that its cash, cash equivalents and marketable securities as of June 30, 2019, together with anticipated product and royalty revenue, anticipated interest income, and anticipated expense reimbursements under our collaboration and license agreements, but excluding any additional program-specific milestone payments, will enable the company to fund its anticipated operating expenses and capital expenditure requirements through at least the end of 2020.

07:03 EDT Broadridge raises annual dividend 11% to $2.16 per share

07:01 EDT Verizon sees FY19 effective tax rate at lower end of 24%-26% forecast range - Backs 2019 outlook for low single-digit percentage growth in adjusted EPS, low single-digit percentage growth in full-year consolidated revenues, and capital spending in the range of $17B-$18B, including the expanded commercial launch of 5G.

06:55 EDT AdvanSix sees 2019 CapEx $150M - Still sees 2019 pre-tax income impact of planned plant turnarounds to be $35M-$40M. Typical ammonium sulfate seasonality expected to drive 3Q19 sequential domestic pricing decline and higher export mix

06:47 EDT Watts Water sees 2H organic sales growth 2%-3% - Sees 2H Americas organic sales growth 3%-4%, with tougher comps in 2H. Sees 2H Europe organic sales growth 1%-2%, APMEA organic sales growth 5%-7%. Comments from slides being presented on the Q2 earnings conference call.

06:44 EDT PBF Energy sees FY19 East Coast total throughput averaging 330K-350K bpd - For the full-year 2019, PBF expects East Coast total throughput to average 330,000 to 350,000 barrels per day; Mid-Continent total throughput is expected to average 150,000 to 160,000 barrels per day; Gulf Coast total throughput is expected to average 180,000 to 190,000 barrels per day and West Coast total throughput is expected to average 150,000 to 160,000 barrels per day.

06:43 EDT PBF Energy sees Q3 East Coast total throughput averaging 350K-370K bpd - For the third quarter 2019, PBF expects East Coast total throughput to average 350,000 to 370,000 barrels per day; Mid-Continent total throughput is expected to average 155,000 to 165,000 barrels per day; Gulf Coast total throughput is expected to average 170,000 to 180,000 barrels per day and West Coast total throughput is expected to average 170,000 to 180,000 barrels per day.

06:37 EDT Marathon Petroleum reports Q2 throughput 3,135MMBOE/D vs 2,038MMBOE/D last year

06:35 EDT Marathon Petroleum CEO 'confident in strengthening fundamentals' - CEO Gary Heminger says: "We simplified our midstream structure into one public company to high-grade commercial opportunities and progressed an impressive slate of high-return projects that are expected to enhance integration across our system. Lastly, today we also highlighted our continued focus on portfolio optimization, which could include asset divestitures to strategically streamline our integrated asset base. We are confident that strengthening business fundamentals throughout the year and the competitive advantages of our integrated business model will both support a growing cash flow profile."

06:34 EDT China Finance Online receives noncompliance letter from Nasdaq - China Finance Online announced that it has received a notification letter from the Nasdaq Listing Qualifications Department notifying the company that, for the last 30 consecutive business days, the closing bid price for the company's American depositary shares, or ADR, has closed below a minimum $1.00 per share required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5550. The Nasdaq deficiency letter has no immediate effect on the listing of the company's ADR, and its ADR will continue to trade on Nasdaqunder the symbol (JRJC) at this time. The company intends to monitor the closing bid price of the company's ADR to allow a reasonable period for the price to rebound from its recent decline but will continue to consider its available options to regain compliance.

06:32 EDT Herc Holdings raises lower end of 2019 adjusted EBItDA view to $735M-$760M - Sees 2019 net fleet CapEx $370M-$410M.

06:27 EDT Emerald Expositions Events announces new $30M share repurchase program

06:22 EDT Leidos announces $200M accelerated share repurchase agreement - Leidos announced that it has entered into an accelerated share repurchase agreement with a financial institution to repurchase $200M of Leidos' common stock. The company expects the accelerated share repurchases to be completed before the end of September. This agreement is part of Leidos' existing share repurchase authorization. In addition, the company may also purchase additional shares in the open market during the quarter.

06:14 EDT Macau reports July casino revenue down 3.5% to 24.45B patacas - Macau's gaming bureau reported July gross revenue from games of fortune in the region decreased 3.5% year-over-year to 24.453B patacas. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO).

06:05 EDT FTC: Equifax victims unlikely to get $125 due to 'overwhelming' response - The Federal Trade Commission is urging consumers affected by Equifax's 2017 data breach to consider signing up for the free credit monitoring offered as part of the settlement. A new FTC blog post notes that because of high interest in the alternative cash payment under the settlement, consumers who choose this option might end up getting far less than $125. The settlement with Equifax announced on July 22 included at least $300M and potentially up to $425M to help consumers recover from the breach. Among the benefits available to consumers affected by the breach is free credit monitoring services or, alternatively, a cash payment if they already have credit monitoring. The FTC blog post notes that the public response to the settlement has been overwhelming. Because the amount of money set aside for the cash payment option is capped at $31M, consumers who select that option may not receive the $125 they had expected. For those who have not submitted a claim, the FTC is recommending that affected consumers consider choosing the free credit monitoring service, which is worth hundreds of dollars and comes with identity theft insurance and restoration services. For consumers who have already chosen the cash option, the settlement administrator will e-mail those consumers and provide them with the opportunity to either (1) submit additional information, or (2) switch to the free credit monitoring service. Consumers can also contact the settlement administrator directly.

06:04 EDT Mednax narrows 2019 adjusted EBITDA view to lower end of $505M at midpoint

05:43 EDT Pfizer announces closing of JV with GlaxoSmithKline - Pfizer (PFE) announced the closing of its joint venture with GlaxoSmithKline (GSK) to combine the parties' respective consumer healthcare businesses to create the world's largest over-the-counter, or OTC, business with robust iconic brands. As previously announced, under the terms of the transaction, Pfizer owns a 32% equity stake in the joint venture and GSK owns 68%. The combined business, which will operate globally as GSK Consumer Healthcare, will be led by CEO Brian McNamara. "The combined brand portfolio forms the world's largest OTC business with leadership positions in pain relief, respiratory and vitamins, minerals and supplements, and therapeutic oral health. In addition, operating together, the two business will hold the number one OTC position in the U.S. and the number two OTC position in China." As part of the agreement, three out of the nine members of the joint venture's board have been appointed by Pfizer and include John Young, Group President, Chief Business Officer; Douglas Giordano, Senior Vice President, Worldwide Business Development and Bryan Supran, Senior Vice President, Deputy General Counsel. The transaction is expected to deliver $650M in peak cost synergies and to be slightly accretive on a full-year basis for Pfizer in each of the first three years following the closing. GSK intends to separate the joint venture as an independent company via a demerger of its equity interest to its shareholders and a listing of the joint venture on the UK equity market. GSK will have the sole right to decide whether and when to initiate a separation and listing for a period of five years following the closing. GSK may also sell all or part of its stake in the joint venture in a contemporaneous IPO. Should a separation and listing occur during the first five years after closing, Pfizer has the option to participate through the distribution of its equity interest in the joint venture to its shareholders or the sale of its equity interest in a contemporaneous IPO. After the fifth anniversary of the closing, both GSK and Pfizer will have the right to decide whether and when to initiate a separation and public listing of the joint venture.

05:37 EDT The Stars Group enters into agreement with Penn National - The Stars Group (TSG) announced that it entered into an agreement with Penn National Gaming (PENN) that grants it options to operate online betting and gaming in states where Penn currently owns or operates casino properties. The agreement covers nine states, which, when combined with The Stars Group's existing market access deals, gives The Stars Group access in up to 20 states. The agreement grants The Stars Group the option to own, operate and brand real-money online sports betting, poker and casino offerings in each of the applicable states subject to license availability, state law and regulatory approvals. As it relates to sports betting, The Stars Group's options currently provide first skin access in Illinois, Indiana, Ohio and Texas, and second skin access in Kansas, New Mexico, Maine, Massachusetts and Michigan. Under the terms of the agreement, Penn will receive a revenue share from the operation of the applicable offerings by The Stars Group, an up-front cash payment of $12.5M, and potential additional cash payments upon and following The Stars Group's exercise of each option.